Last $8.56 USD
Change Today +0.14 / 1.66%
Volume 494.3K
AFFX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 5:20 PM 07/23/14 All times are local (Market data is delayed by at least 15 minutes).

affymetrix inc (AFFX) Snapshot

Open
$8.49
Previous Close
$8.42
Day High
$8.63
Day Low
$8.43
52 Week High
01/21/14 - $9.80
52 Week Low
07/31/13 - $3.70
Market Cap
622.7M
Average Volume 10 Days
781.8K
EPS TTM
$-0.32
Shares Outstanding
72.7M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for AFFYMETRIX INC (AFFX)

affymetrix inc (AFFX) Related Businessweek News

No Related Businessweek News Found

affymetrix inc (AFFX) Details

Affymetrix, Inc. provides life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein, and cell level primarily in the United States, Europe, Latin America, and Asia. The company operates in two segments, Affymetrix Core and eBioscience. The Affymetrix Core segment is engaged in the development, manufacture, and commercialization of systems for genetic analysis in the life sciences and diagnostic industry. This segment develops and markets GeneChip gene expression products and services; genotyping product line, such as the Axiom product line; arrays and assays with clinical research applications, such as the CytoScan and OncoScan products; QuantiGene line of singleplex and multiplex assays to serve customers in the research and translational medicine markets; and GeneTitan family of products consisting of the GeneTitan instrument system that runs genotyping and gene expression array plates. It also offers life science reagents, such as ExoSAP-IT for a reagent for the clean-up of polymerase chain reaction, and HotStart-IT reagents to inhibit primer dimer formation; enzymes; purification kits; and biochemicals for life science researchers. The eBioscience segment is involved in the development, manufacturing, marketing, and distribution of research products in the areas of flow cytometry, immunoassays, microscopic imaging, and other protein-based analyses. This segment offers a portfolio of antibodies and reagents, as well as a range of the QuantiGene and Procarta assay portfolio. The company sells its products directly and through third party distributors to genomic research centers, academic institutions, government, and private laboratories, as well as pharmaceutical, diagnostic, and biotechnology companies. Affymetrix, Inc. was founded in 1991 and is headquartered in Santa Clara, California.

1,100 Employees
Last Reported Date: 05/5/14
Founded in 1991

affymetrix inc (AFFX) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $498.6K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $281.8K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $376.5K
Chief Commercial Officer and Executive Vice P...
Total Annual Compensation: $331.3K
Compensation as of Fiscal Year 2013.

affymetrix inc (AFFX) Key Developments

Affymetrix Inc. and BioDiscovery, Inc. Launches New Analysis Software, Nexus Copy Number

Affymetrix and BioDiscovery, Inc. announced the launch of a new analysis software, Nexus Copy Number for Affymetrix, which is specifically for data generated by Affymetrix' genetic analysis platforms in cancer research, including CytoScan(R) Cytogenetics Suite and OncoScan(R) FFPE Assay Kit. CytoScan Cytogenetics Suite and OncoScan FFPE Assay Kit are key parts of Affymetrix cancer portfolio. Researchers have been finding CNVs and copy neutral changes in liquid and solid tumor samples. With the use of Nexus Copy Number, an advanced discovery tool for interrogating large data sets, researchers have been able to identify biomarkers that drive disease progression. The new Nexus Copy Number for Affymetrix software offers researchers a version of the Nexus Copy Number software that is easier to access and has been specifically tailored for Affymetrix' assays.

Affymetrix Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-05-2014 11:00 AM

Affymetrix Inc. Presents at Jefferies 2014 Global Healthcare Conference, Jun-05-2014 11:00 AM. Venue: Grand Hyatt, New York, New York, United States. Speakers: Franklin R. Witney, Chief Executive Officer, President and Director, Gavin H. J. Wood, Chief Financial Officer, Principal Accounting Officer and Executive Vice President.

Affymetrix Inc. and Leica Biosystems Announce Launch of Fully Automated RNA in situ Hybridization Assays

Affymetrix Inc. and Leica Biosystems announced the launch of Affymetrix' fully automated RNA in situ hybridization assays ViewRNA(TM) eZ Assays on the Leica BOND RX staining platform. These assays detect coding RNA as well as novel non-coding markers in formalin-fixed paraffin-embedded (FFPE) tissues. Dedicated for research use only, the assays provide researchers with a powerful automated solution for drug discovery, translational research, and the development of new diagnostic tests for personalized medicine. The automation significantly reduces hands-on time and assay run time for profiling single-cell gene expression. The Leica BOND RX system automates the staining process, bringing all the benefits of consistency, reduced labor, and speed. This fully automated assay is hands-free from tissue de-waxing to counter staining, and offers high sensitivity, specificity, and reproducibility with easy standardization across laboratories. ViewRNA eZ Assays represent a major technological advancement offering a robust and reliable platform to easily interrogate the function and disease relevance of any expressed genes. Affymetrix' ViewRNA eZ Assays on the Leica BOND RX platform are now available for research applications. The ViewRNA eZ staining protocol is pre-loaded onto the Leica BOND RX, and the staining kit optimized for FFPE samples and probes of choice are available from Affymetrix.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
AFFX:US $8.56 USD +0.14

AFFX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abcam PLC 406.50 GBp +19.50
Enzo Biochem Inc $5.24 USD +0.08
Fluidigm Corp $28.96 USD +1.40
Luminex Corp $17.72 USD +0.29
Pacific Biosciences of California Inc $5.51 USD +0.14
View Industry Companies
 

Industry Analysis

AFFX

Industry Average

Valuation AFFX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 1.8x
Price/Book 2.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact AFFYMETRIX INC, please visit www.affymetrix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.